Analyzing noninferiority trials: it is time for advantage deficit assessment – an observational study of published noninferiority trials by Gladstone BP, Vach W

Get full text

Excess resource use and cost of drug-resistant infections for six key pathogens in Europe: a systematic review and Bayesian meta-analysis by Kingston, R, Vella, V, Pouwels, KB, Schmidt, JE, El-Abasiri, RAA, Reyna-Villasmil, E, Hassoun-Kheir, N, Harbarth, S, Rodríguez-Baño, J, Tacconelli, E, Arieti, F, Gladstone, BP, de Kraker, MEA, Naylor, NR, Robotham, JV

A systematic review on the excess health risk of antibiotic-resistant bloodstream infections for six key pathogens in Europe by Hassoun-Kheir, N, Guedes, M, Ngo Nsoga, M-T, Argante, L, Arieti, F, Gladstone, BP, Kingston, R, Naylor, NR, Pezzani, MD, Pouwels, KB, Robotham, JV, Rodríguez-Baño, J, Tacconelli, E, Vella, V, Harbarth, S, de Kraker, MEA

EPI-Net One Health reporting guideline for antimicrobial consumption and resistance surveillance data: a Delphi approach by Babu Rajendran, N, Arieti, F, Mena-Benítez, CA, Galia, L, Tebon, M, Alvarez, J, Gladstone, BP, Collineau, L, De Angelis, G, Duro, R, Gaze, W, Göpel, S, Kanj, SS, Käsbohrer, A, Limmathurotsakul, D, Lopez de Abechuco, E, Mazzolini, E, Mutters, NT, Pezzani, MD, Presterl, E, Renk, H, Rodríguez-Baño, J, Săndulescu, O, Scali, F, Skov, R, Velavan, TP, Vuong, C, Tacconelli, E